SCHEMBL3300336

SCHEMBL3300336

CCCCOc1cc(CC)ccc1[SiH](O[SiH](c1ccc(CC)cc1OCCCC)c1ccc(CC)cc1OCCCC)c1ccc(CC)cc1OCCCC

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GLA P06280 1/20 0.39
SMN1; SMN2 Q16637 1/20 0.39
CYP1A2 P05177 2/20 0.38
CYP2C9 P11712 1/20 0.38
CYP2C19 P33261 1/20 0.38
TLR8 Q9NR97 1/20 0.37
BACE1 P56817 1/20 0.35
BIRC5 O15392 1/20 0.35
CNR2 P34972 1/20 0.35
ATM Q13315 1/20 0.35
PDE4A P27815 2/20 0.34
MAPK1 P28482 2/20 0.34
PDE4D Q08499 2/20 0.34
TNF P01375 1/20 0.34
LMNA P02545 1/20 0.34
MAPT P10636 1/20 0.34
PDE4B Q07343 1/20 0.34
PDE4C Q08493 1/20 0.34
PDE3B Q13370 1/20 0.34
PDE3A Q14432 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3301693 0.89 GLA (0.43) GLASMN1; SMN2CYP1A2CYP2C9CYP2C19
SCHEMBL3296571 0.85 CALM1 (0.37) SMN1; SMN2CYP1A2CYP2C9PDE4AMAPK1
SCHEMBL3295354 0.83 LTA4H (0.43) CYP1A2CYP2C9CYP2C19TLR8MAPT
SCHEMBL3298043 0.82 L3MBTL1 (0.41) GLASMN1; SMN2CYP1A2CYP2C9CYP2C19
SCHEMBL3295374 0.80 PTGS2 (0.52) SMN1; SMN2CYP1A2ATMMAPK1LMNA
SCHEMBL13462924 0.79 BIRC5 (0.51) GLASMN1; SMN2CYP1A2CYP2C9CYP2C19
SCHEMBL3299743 0.79 CYP1A2 (0.40) GLASMN1; SMN2CYP1A2CYP2C9CYP2C19
SCHEMBL3301492 0.78 KDM4E (0.40) SMN1; SMN2CYP1A2CYP2C9CYP2C19TLR8
SCHEMBL3296160 0.76 CYP1A2 (0.55) CYP1A2CYP2C9CYP2C19TLR8ATM
SCHEMBL12044516 0.76 TSHR (0.44) GLASMN1; SMN2CYP1A2CYP2C9CYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7741393-B2 Organic silicon-based compound and method of producing the same SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2010-06-22 US disclosed
US-20070203275-A1 Organic Silicon-Based Compound And Method Of Producing The Same SUMITOMO CHEMICAL COMPANY, LIMITED 2007-08-30 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070203275-A1 Organic Silicon-Based Compound And Method Of Producing The Same ARSA, OR10J3, HDAC10 GLA 304/4885SMN1; SMN2 1035/4885CYP1A2 945/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.